HealWELL AI Inc. Class A · TSX:AIDX
HealWELL AI Inc. Class A — Investor Presentation (July 2024)
23 slides from HealWELL AI Inc. Class A's investor presentation, Jul 12, 2024
Slide 1: AI Accelerated Preventative Healthcare
Al ACCELERATED PREVENTATIVE HEALTHCARE HEALWELL*4®'! INVESTOR PRESENTATION TSX: AIDX JULY 2024
Slide 2: Disclaimer & Forward-Looking Statements
HEALWELL*" TSX: AIDX | 2 Disclaimer & Forward-Looking Statements IMPORTANT: YOU MUST READ THE FOLLOWING BEFORE CONTINUING. This presentation has been prepared by HEALWELL Allnc. (t/k/a MCI Onehealth Technologies Inc., the “Company’] for information purposes only and does not constitute an offer to s
Slide 3: HEALWELL is endeavoring to build the world's leading healthcare technology company
HEALWELL*" i TSX: AIDX | 3 HEALWELL is endeavoring to build the world’s leading healthcare technology company focused on Al and data science for preventative care. Our mission is to improve healthcare and save lives through the early identification and detection of disease. INVESTOR PRESENTATION
Slide 4: Company Overview
HEALWELL*" TSX: AIDX | 4 Company Overview Headquarters: * Al-enabled clinical decision support is the future of healthcare. ‘ * HEALWELL provides leading Al tools and software to healthcare " providers, with the ability to screen and detect hundreds of rare, Number of Employees: complex and chronic
Slide 5: Accelerated Pace
HEALWELL*" TSX: AIDX | 5 Accelerated Pace October 2, 2023 November 9, 2023 December 22, 2023 April 22, 2024 June 13, 2024 $10M convertible Investment and strategic $11.5 million bought- $20.0 million bought- ‘BioPharma’ acquisition to debenture financing partnership with deal financing deal financin
Slide 6: Early Detection Saves Lives
HEALWELL*" TSX: AIDX | 6 Ea rly Detection Stage of Diagnoses and ° 5 Year Survival Rate® Saves Lives Economic Impact of Late or Misdiagnosis The yearly economic cost of cancer alone through 11% healthcare expenditure and loss of productivity was estimated to be over US$1 trillion.’ MORTALITY RATE If
Slide 7: Our Ecosystem
HEALWELL*" —_ —_ Our Ecosystem Artificial Intelligence & Data Science ° Pentavere * Khure Health INVESTOR PRESENTATION HEALWELL”" & cA 7 TSX: AIDX | 7 Pr“ Healthcare Software > ~ ~~ ° Intrahealth ° VeroSource “6 Clinical Research & Patient Services ° BioPharma * Canada Phase Onward * Polyclinic Grou
Slide 8: Business Model
HEALWELL*" TSX: AIDX | 8 Business Model HEALWELL Generates Revenue in 3 Distinct Categories: Al and Data Science Re-occurring Revenue ~70% Gross Margin (at scale) High Growth Customers: * Pharma + Life Sciences Companies * Precision Medicine Companies Healthcare Software SaaS Revenue ~80% Gross Marg
Slide 9: Expanding Commercial Footprint
HEALWELL* Expanding Commercial Footprint Healthcare Software Al and Data Science y =e) PENTAVERE © Intrahealth A HEALWELL*! COMPANY 7 hospitals, 9 Pharma relationships 415,000 healthcare providers Khure © Health VeroSource Solutions 6 large Pharma relationships 5 provincial health authorities INVEST
Slide 10: Artificial Intelligence & Data Science
HEALWELL* Artificial Intelligence & Data Science HEALWELL applies best-in-class Al technology & analytics to large clinical data sets. Our Al technology generates lists of actionable clinical insights for physicians; true Clinical Decision Support (CDs) TSX: AIDX |10 This results in the early detect
Slide 11: Exclusive access to more consenting clinicians
HEALWELL* Exclusive access to more consenting clinicians will allow us to continually refine our algorithms, further positioning us to become a leading force in the field of disease detection software and preventative healthcare. INVESTOR PRESENTATION
Slide 12: Financial Projections
TSX: AIDX [12 HEALWELL* Financial Projections Revenue (C$M) Adj. EBITDA (C$M) 78.3 724 62 & & g m2 g || 5 = -24 13 -8.0 ° = * 2023 2024E 2025E 2026E 2023 2024E 2025E 2026E Current Annualized Revenue Run-Rate: $65M+ 2024, 2025, 2026 revenue estimates based on analyst consensus sourced from S&P Capita
Slide 13: M&A Strategy
HEALWELL*" M&A Strategy WELL Health is a capital allocator, having completed >$1B in M&A across more than 75 transactions. HEALWELL intends to adopt a similar acquisitive growth strategy and will be WELL’s capital allocation vehicle for preventative health and Al targets. Target Company Profile? ° A
Slide 14: Pentavere and Intrahealth
HEALWELL*" TSX: AIDX | 14 PENTAVERE Pentavere is a healthcare Al company that helps identify patients for approved medications or interventions - finding patients that have fallen through the cracks. Developed and validated Al capabilities in data structuring and abstraction; a key competency to unl
Slide 15: VeroSource and BioPharma
HEALWELL*" TSX: AIDX | 15 © Source VeroSource is a Canadian based, multi-service software and services technology company focused on providing healthcare solutions to provincial healthcare systems. Securely integrates health data from sources such as EMRs, pharmacies and hospital information systems
Slide 16: Challenging Healthcare Headwinds
HEALWELL*" TSX: AIDX |16 Challenging Healthcare Headwinds PATIENTS Q * Missed diagnosis and late diagnosis leads to pain WY and suffering - patients are falling through the cracks * Worsening waiting times for primary and specialist care consultations leads to late diagnosis PROVIDERS/PHYSICIANS » 4
Slide 17: Generational Market Opportunity
HEALWELL* Generational Market Opportunity Alis ushering in a new age of healthcare, offering the medical and health sectors greater capacity and more precision in everything from diagnoses, treatments, research and more’ The Al in healthcare marketis forecasted to grow from US$19Bn in 2022 to US$281
Slide 18: Capital Structure
HEALWELL*" Capital Structure TICKER TSX: AIDX ISSUED & OUTSTANDING™ 161.0M CONVERTIBLE DEBENTURE SHARES() 50.5M WARRANTS) 40.1M OPTIONS / xSUs 7.5M CASH $14.5M TSX: AIDX | Proforma Economic Ownership(™) (Fully Diluted Basis) = WELL Health Institutional Investors = Mgmt/Board = Free Float 18 (1) The
Slide 19: Proven and Experienced Team
HEALWELL* TSX: AIDX | 19 Proven and Experienced Team — Dr. Alexander Dobranowski Anthony Lam CHIEF EXECUTIVE OFFICER CHIEF FINANCIAL OFFICER Medical doctor and entrepreneur with 15+ years of 20+ years of international senior finance and operational clinical and technology experience. CEO of HEALWELL
Slide 20: Board of Directors
HEALWELL* Board of Directors Hamed Shahbazi CHAIRMAN Founder, CEO & Chairman at WELL Health. 20+ years of experience as a technology focused operator. Founder of TIO Networks, acquired by PayPal for $304M. Key driver in more than 70 M&A transactions worth approx. ~$2B. Kingsley Ward > DIRECTOR 4 ‘ F
Slide 21: Share Price Performance
HEALWELL*" Share Price Performance TSX: AIDX Oct i016 23 Mow % 20 27Dec 11 18 20243 16 2% Feb 12 20 26Mar 11 18 25Apr_@ 45 22 Mayo 13 2127 Jun 40 17 24 Jul Oct 1016 22 Wow 2 20 27Dec 11 16 20243 19 22” Feb 12 2026Mar 11 12 25Apr 2 15 22 Mayo 12 2127 Juni 17 24 Jul Stock Graph as of 2024-07-05 INVEST
Slide 22: Investment Highlights
HEALWELL*" TSX: AIDX | 22 Investment Highlights * Healthcare Al and data science company that has proven results and revenue from 6 of the top 10 pharma ¢ WELL Health relationship accelerates our growth with exclusive access to providers and multi-national footprint ¢ Multi-billion-dollar market opp
Slide 23: Detect, Discover, Diagnose
DETECT, DISCOVER, DIAGNOSE HEALWELL*4®'! 460 College Street, Unit 301 Toronto, ON M6G 1A1 | 416-440-4040 © ir@bhealwell.ai in |X| f | © INVESTOR PRESENTATION TSX: AIDX JULY 2024